The Evan Bray Show - Matthew Kaeberlein - October 15th, 2024

Loading player...
A drug typically prescribed to suppress the immune systems of organ transplant patients is being used by everyday people, now, with the hope of delaying aging and age-related diseases. Dr. Matthew Kaeberlein, CEO of Optispan, an American healthcare technology company, joins Evan to discuss the hype around rapamycin.
15 Oct 2024 1PM English South Africa News Commentary

Other recent episodes

The Real Cost of the Industrial Carbon Tax

Canada’s industrial carbon tax is set to rise again, and it’s sparking a lot of debate about what that means for the economy. Critics argue it could lead to higher costs, reduced investment and pressure on jobs. Ross McKitrick, professor in the Department of Economics and Finance, specializing in environmental…
2 Apr 10AM 15 min

Regina Pat Canadians Look to Punch Their Ticket to National Cup

The Regina Pat Canadians are looking to punch their ticket to the National Telus Cup, but before they can do that, they're hosting the Western Regional Tournament. Todd Liskowich, Chair of the Organizing Committee for the 2026 Telus Cup Western Regional Tournament and Ryan Hodgins, Head Coach of the Regina…
1 Apr 1PM 10 min